Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in

  News Archive

Protea, Protein Metrics Collaboration to Focus on Biotherapeutics
Monday, February 22, 2016
Companies collaborate to advance new analytical capabilities for use in the development of protein biotherapeutics.

Vaccine Against Dangerous Designer Opioids
Thursday, February 18, 2016
With use of synthetic opioid "designer drugs" on the rise, scientists from The Scripps Research Institute (TSRI) have a new strategy to curb addiction and even prevent fatal overdoses.

Paper Published Based on RNA Game
Thursday, February 18, 2016
Video-gamers have co-authored a paper describing a new set of rules for determining the difficulty of designing structures composed of RNA molecules.

Fighting Cancer and Infections with T Cell Therapy
Wednesday, February 17, 2016
The quest to bring immunotherapy into widespread clinical use against cancer and infectious diseases has made great strides in recent years. For example, clinical trials of adoptive T cell therapy are yielding highly promising results.

TAxI Shuttles Protein Cargo into Spinal Cord
Wednesday, February 17, 2016
A small peptide, TAxI, holds hope for administering treatments for motor neuron disorders via a muscle injection.

Biosensors Light Up High-Throughput Metabolic Engineering
Wednesday, February 17, 2016
Genetically encoded fluorescent biosensors allow researchers to see how products form in real time in microorganisms, and to test billions of candidates at a time.

Velesco Pharma Opens New Analytical Testing Laboratory
Friday, February 12, 2016
Company has announced that it has opened new CGMP-compliant analytical testing laboratory for development of vaccines and biologics with improved stability and preserved potency.

Qualicaps® Acquires Genix Industria Farmaceutica Ltda
Friday, February 12, 2016
Company has announced that acquisition allows the company to effectively expand its global presence from operating sites in Japan, Spain, Romania, Canada and the USA, to include Brazil.

Regeneron Joins Human Vaccines Project
Thursday, February 11, 2016
Regeneron Pharmaceuticals has announced that it has joined the Human Vaccines Project, a public-private partnership to help discover and develop new vaccines and immunotherapies for infectious diseases and cancer.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 1883

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos